Parametric Portfolio Associates’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $1.45M | Buy |
|
|||||
|
2021
Q4 | $451K | Sell |
|
|||||
|
2021
Q3 | $821K | Sell |
|
|||||
|
2021
Q2 | $1.04M | Buy |
|
|||||
|
2021
Q1 | $778K | Buy |
|
|||||
|
2020
Q4 | $388K | Buy |
|
|||||
|
2020
Q3 | $254K | Sell |
|
|||||
|
2020
Q2 | $213K | Buy |
|
|||||
|
2020
Q1 | $137K | Sell |
|
|||||
|
2019
Q4 | $459K | Buy |
|
|||||
|
2019
Q3 | $326K | Buy |
|
|||||
|
2019
Q2 | $431K | Buy |
|
|||||
|
2019
Q1 | $43K | Sell |
|
|||||
|
2018
Q4 | $54K | Sell |
|
|||||
|
2018
Q3 | $205K | Sell |
|
|||||
|
2018
Q2 | $199K | Buy |
|
|||||
|
2018
Q1 | $106K | Buy |
|
|||||
|
2017
Q4 | $87K | Sell |
|
|||||
|
2017
Q3 | $63K | Sell |
|
|||||
|
2017
Q2 | $81K | Sell |
|
|||||
|
2017
Q1 | $102K | Buy |
|
|||||
|
2016
Q4 | $66K | Sell |
|
|||||
|
2016
Q3 | $336K | Sell |
|
|||||
|
2016
Q2 | $288K | Buy |
|
|||||
|
2016
Q1 | $262K | Sell |
|
|||||
|
2015
Q4 | $392K | Buy |
|
|||||
|
2015
Q3 | $308K | Buy |
|
|||||
|
2015
Q2 | $269K | Buy |
|
|||||
|
2015
Q1 | $263K | Buy |
|
|||||
|
2014
Q4 | $160K | Buy |
|
|||||
|
2014
Q3 | $87K | Sell |
|
|||||
|
2014
Q2 | $261K | Sell |
|
|||||
|
2014
Q1 | $335K | Buy |
|
|||||
|
2013
Q4 | $221K | Buy |
|
|||||
|
2013
Q3 | $142K | Buy |
|